Transgene Biotek (526139)
TURNAROUNDScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹9.56 |
| Market Cap | ₹77.21 Cr |
| P/E Ratio | 0 |
| ROCE | -1.75% |
| ROE | 28.3% |
| Dividend Yield | 0% |
| Profit Growth | -311.11% |
| Debt/Equity | — |
| Sales Growth | -37.5% |
| 52-Week Range | ₹1.83 — ₹9.56 |
| Sector | Healthcare Services |
Transgene Biotek trades with ROCE of -1.75%, ROE of 28.3%, profit growth of -311.11%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer